For more information, please visit www.lexariabioscience.com
One study of 30 patients on nasal glutathione dosed at either 300mg or 600mg daily in three divided doses vs placebo over a three month period found significant improvement in UPDRS scores in the treatment arms over placebo while other measures of toxicity such as cell counts, liver enzymes, creatinine, blood urea nitrogen, and urinalysis were not significantly different between placebo and treatment groups
The best way to find out if you're a candidate is a real conversation with Meriem, not a five-question online quiz
114 This may represent a pivotal shift, particularly for GLP-1RA, as it is based on metabolic improvement and has already been explored in some trials for exploratory research
Unlike GLP-1 agonists that suppress appetite, 5-amino-1MQ targets the metabolic dysfunction at its source